"British-Swedish multinational pharma AstraZeneca will expand its drugs-making operations in Australia, with a A$200 million investment in an existing Sydney facility.
Announced on 7 February 2020, the investment will expand manufacturing of respiratory medicines at North Ryde. This include therapies for asthma and chronic obstructive pulmonary disease.
The expanded Sydney facility will create 250 jobs. It will also help increase the value of AstraZeneca’s Australian exports to approximately A$4.4 billion over the next four years."
Editors Note: What great timing for AstraZeneca ... almost as if they had a crystal ball!